Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Feasibility of the BinaxNOW™ COVID-19/Flu A&B Combo in the Southern Hemisphere

NCT06928129 is registered in ClinicalTrials.gov with Abbott Rapid Dx as lead sponsor.

NCT NCT06928129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06928129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Feasibility of the BinaxNOW™ COVID-19/Flu A&B Combo in the Southern Hemisphere
Lead sponsor
Abbott Rapid Dx
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 30, 2025
Completion date
November 1, 2025
Enrollment
700 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, influenza type a, influenza type b